InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,452.40
(
0.19%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.56
(
0.52%
)
Bitcoin
65,193.47
(
1.87%
)
Post# of 458360
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

blu_1

Send PM Follow Ignore
Followers 23
Posts 911
Boards Moderated 0
Alias Born 10/22/2015

blu_1

Re: gbrown6332 post# 400862

Tuesday, 01/31/2023 11:40:58 PM

Tuesday, January 31, 2023 11:40:58 PM

Post# of 458360
I *think* Piotr seems to imply that precision medicine was not applied to the enrollment of the Ph2b/3 trial, meaning that Anavex enrolled both people with normal sigma-1 receptors and abnormal receptors. Is that correct, or did Anavex enroll just those with the predominant "wild type" (normal) gene for sigma-1 receptors?
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!